Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Apr;14(2):794-804.
doi: 10.1002/jcsm.13173. Epub 2023 Jan 28.

Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function

Affiliations
Randomized Controlled Trial

Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function

Elena Monti et al. J Cachexia Sarcopenia Muscle. 2023 Apr.

Abstract

Background: Ageing is accompanied by a progressive loss of skeletal muscle mass and strength, potentially determining the insurgence of sarcopenia. Evidence suggests that motoneuron and neuromuscular junction (NMJ) degeneration contribute to sarcopenia pathogenesis. Seeking for strategies able to slow down sarcopenia insurgence and progression, we investigated whether a 2-year mixed-model training involving aerobic, strength and balance exercises would be effective for improving or preserving motoneuronal health and NMJ stability, together with muscle mass, strength and functionality in an old, sarcopenic population.

Methods: Forty-five sarcopenic elderly (34 females; 11 males) with low dual-energy X-ray absorptiometry (DXA) lean mass and Short Physical Performance Battery (SPPB) score <9 were randomly assigned to either a control group [Healthy Aging Lifestyle Education (HALE), n = 21] or an intervention group [MultiComponent Intervention (MCI), n = 24]. MCI trained three times per week for 2 years with a mix of aerobic, strength and balance exercises matched with nutritional advice. Before and after the intervention, ultrasound scans of the vastus lateralis (VL), SPPB and a blood sample were obtained. VL architecture [pennation angle (PA) and fascicle length (Lf)] and cross-sectional area (CSA) were measured. As biomarkers of neuronal health and NMJ stability status, neurofilament light chain (NfL) and C-terminal agrin fragment (CAF) concentrations were measured in serum. Differences in ultrasound parameters, NfL and CAF concentration and physical performance between baseline and follow-up were tested with mixed ANOVA or Wilcoxon test. The relationship between changes in physical performance and NfL or CAF concentration was assessed through correlation analyses.

Results: At follow-up, MCI showed preserved VL architecture (PA, Lf) despite a reduced CSA (-8.4%, P < 0.001), accompanied by maintained CAF concentration and ameliorated overall SPPB performance (P = 0.007). Conversely, HALE showed 12.7% decrease in muscle CSA (P < 0.001), together with 5.1% and 5.5% reduction in PA and Lf (P < 0.001 and P = 0.001, respectively), and a 6.2% increase in CAF (P = 0.009) but improved SPPB balance score (P = 0.007). NfL concentration did not change in either group. In the population, negative correlations between changes in CAF concentration and SPPB total score were found (P = 0.047), whereas no correlation between NfL and SPPB variations was observed.

Conclusions: The present findings suggest that our 2-year mixed aerobic, strength and balance training seemed effective for preventing the age and sarcopenia-related increases in CAF concentration, preserving NMJ stability as well as muscle structure (PA and Lf) and improving physical performance in sarcopenic older individuals.

Keywords: C-terminal agrin fragment (CAF); elderly; exercise intervention; neurofilament light chain (NfL); sarcopenia; skeletal muscle.

PubMed Disclaimer

Conflict of interest statement

Elena Monti, Sara Tagliaferri, Sandra Zampieri, Fabio Sarto, Giuseppe Sirago, Martino V. Franchi, Andrea Ticinesi, Yari Longobucco, Elisa Adorni, Fulvio Lauretani, Riccardo Calvani and Marco V. Narici declare that they have no conflict of interests. Stephan Von Haehling, Emanuele Marzetti, Roberto Bernabei, Matteo Cesari and Marcello Maggio have received research grants from the Innovative Medicines Initiative – Joint Undertaking (IMI‐JU 115621).

Figures

Figure 1
Figure 1
Muscle size adaptations to 2‐year intervention: vastus lateralis (VL), pennation angle (PA) (A), length of fascicles (Lf) (B) and cross‐sectional area (CSA) obtained at the 35% of the femur length (C) at baseline (BL) and follow‐up for control (HALE) and intervention (MCI) groups, determined by mixed ANOVA. **P < 0.01 follow‐up versus BL. ***P < 0.001 follow‐up versus BL. ****P < 0.0001 follow‐up versus BL.
Figure 2
Figure 2
C‐terminal agrin fragment (CAF) (A) and neurofilament light chain (NfL) (B) serum concentration variations in response to the 2‐year intervention: CAF and NfL values at baseline (BL) and follow‐up for the control (HALE) and intervention (MCI) groups, determined by mixed ANOVA. NfL values did not pass the normality test; thus, log10 transformation was applied; thereafter, normality test was passed. **P < 0.01 follow‐up versus BL.
Figure 3
Figure 3
C‐terminal agrin fragment (CAF) (A) and neurofilament light chain (NfL) (B) serum concentration differences between a young (Young) reference population measured in our laboratory and the pooled old sarcopenic (O‐Sarc) participants of the present study at baseline. Differences were assessed via unpaired t‐test. NfL values did not pass the normality test; thus, log10 transformation was applied; thereafter, normality test was passed. ****P < 0.0001 versus Young.

References

    1. Cruz‐Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019;48:16–31. - PMC - PubMed
    1. Gonzalez‐Freire M, de Cabo R, Studenski SA, Ferrucci L. The neuromuscular junction: Aging at the crossroad between nerves and muscle. Front Aging Neurosci 2014;6:1–11. - PMC - PubMed
    1. Kalinkovich A, Livshits G. Sarcopenia ‐ The search for emerging biomarkers. Ageing Res Rev 2015;22:58–71. - PubMed
    1. Bütikofer L, Zurlinden A, Bolliger MF, Kunz B, Sonderegger P. Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia. FASEB J 2011;25:4378–4393. - PubMed
    1. Moreira‐Pais A, Ferreira R, Oliveira PA, Duarte JA. A neuromuscular perspective of sarcopenia pathogenesis: Deciphering the signaling pathways involved. GeroScience 2022;44:1199–1213. - PMC - PubMed

Publication types